The Digital Speaker (Page 14)

When Technologies Collide: Preparing for the Convergence Effect

Biggest disruptions come from convergence: AI + robotics = autonomous operations. AI + quantum = new encryption. AI + biotech = drug discovery revolution. Single-technology strategies are unprepared for intersections.

AI Readiness: Why Bigger Organizations Aren't Always Better Prepared

Size doesn't determine readiness. Large organizations lead on scanning and governance (resources) but lag on execution agility and workforce transformation at scale. Smaller organizations frequently outperform.

Synthetic Minds | AI's Biggest Bet is that Compute Stays Scarce Forever

Amazon's researchers found a flaw in Anthropic's most powerful AI. Amazon CEO Andy Jassy phoned the US Treasury Secretary Scott Bessent. The Commerce Department then ordered Anthropic to switch off its two best AI models for everyone outside America. Amazon funds Anthropic and hosts it on its cloud.

Woolworths Group's AI Readiness: Olive's Ambition, Thin Spine

A WAVE assessment of Woolworths Group: Olive on Gemini, Scan&Go, and a 6.2/16 score that exposes the gap between announceable AI and evidence-able governance.

When Should AI Decide Without Humans? A Framework

Decision authority: when should AI decide autonomously vs. human judgment in the loop? Organizations need this framework now, while decisions are still supervised, so it's ready before AI exceeds the humans overseeing it.

Generative AI: From Shadow Usage to Enterprise Strategy

Every organization has shadow generative AI. Transition from shadow to sanctioned requires three things: acceptable use policy, workforce training, governance that enables rather than bans.

AI Readiness for Healthcare: The Patient Safety Imperative

Healthcare: governance is life-or-death. Clinical AI validation, patient data governance, regulatory compliance under TGA, FDA, EMA aren't optional. And workforce augmentation must be positioned as enhancement, never replacement.

Synthetic Minds | Surgery, Drugs and Biosecurity Share the Same Brain

Nvidia has shipped the first commercially licensed surgical AI brain to robot makers. Jazz Pharmaceuticals has committed up to $2.46 billion and Merck up to $510 million to two AI antibody platforms. BARDA has closed its window on AI antivirals. The substrate of medicine has been quietly outsourced.

AI Readiness for Banks and Financial Services

Financial services is regulation-hardened—strong on governance. But workforce enablement lags. Non-technical staff in relationship management and compliance aren't equipped for AI-assisted workflows.

The 4 Handoffs That Kill AI Strategy (and How to Fix Them)

AI strategies fail at transitions between capabilities. Scanning insights that never become experiments. Experiments that never survive governance. Governed tools that never reach prepared users. Identifying which handoff is broken is the fastest path to fixing it.

All posts